SynthesisFrontiers in oncology2026

Immunotherapy plus targeted therapy for recurrent or metastatic head and neck squamous cell carcinoma: an updated meta-analysis and subgroup analysis by target mechanism.

Wen Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.